BCM
SPPI

Bayesian Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bayesian Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-15,854
Closed -$223K – 764
2017
Q3 		$223K Buy
+15,854
New +$143K 0.05% 411
2016
Q3 		– Sell
-20,385
Closed -$134K – 546
2016
Q2 		$134K Buy
+20,385
New +$144K 0.08% 351

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bayesian Capital Management's SPPI Position: Q4 2017 in Review

Bayesian Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2017, closing a stake of 15,854 shares — an estimated $223K sold.

Bayesian Capital Management first reported a position in SPPI in Q2 2016 and held it in 2 quarters. The position peaked at $223K in Q3 2017. 157 funds tracked by Wall St. Rank hold SPPI as of Q4 2017.

  • Bayesian Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Bayesian Capital Management sold 15,854 Spectrum Pharmaceuticals Inc shares in Q4 2017, an estimated $223K.
  • Bayesian Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2016 and held it in 2 quarters.
  • Bayesian Capital Management's Spectrum Pharmaceuticals Inc position peaked at $223K in Q3 2017.
  • 157 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2017.

Based on Bayesian Capital Management's 13F filing for Q4 2017, filed 12 Feb 2018.